Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

2.

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

3.

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

4.

Stereotactic Radiation Linked to Better Brain Mets Outcomes

5.

Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot